HAVRIX AD 1440 VACUNA C/1 JERINGA PRELLENADA CARBOXIMETILCELULOSA SODICA 0.5% PRINCIPIO ACTIVO: NIFUROXAZIDA

Description

PRINCIPIO ACTIVO: NIFUROXAZIDA

Hiperplasia gingival

Mantener en su envase original y fuera del alcance de los niños

PRINCIPIO ACTIVO: CLONIXANATO DE LISINA

HAVRIX AD 1440 VACUNA C/1 JERINGA PRELLENADA CARBOXIMETILCELULOSA SODICA 0.5% PRINCIPIO ACTIVO: NIFUROXAZIDACaja C 1 Jeringa Prellenada

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy